TQB2618
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TQB2618, covering 2022-12-09 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]